iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Shares Sold by Fisher Asset Management LLC

Fisher Asset Management LLC lowered its stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 3.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,226,694 shares of the company’s stock after selling 125,550 shares during the period. Fisher Asset Management LLC owned 31.95% of iShares U.S. Pharmaceuticals ETF worth $212,058,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in IHE. Pallas Capital Advisors LLC purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 4th quarter valued at about $3,829,000. Strategic Financial Concepts LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF during the 4th quarter valued at approximately $1,312,000. Grimes & Company Inc. acquired a new stake in iShares U.S. Pharmaceuticals ETF during the 4th quarter valued at approximately $967,000. Flow Traders U.S. LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF during the 3rd quarter valued at approximately $839,000. Finally, Commonwealth Retirement Investments LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF during the 4th quarter valued at approximately $536,000.

iShares U.S. Pharmaceuticals ETF Stock Up 1.2 %

Shares of NYSEARCA IHE opened at $72.67 on Friday. iShares U.S. Pharmaceuticals ETF has a fifty-two week low of $62.68 and a fifty-two week high of $73.11. The business has a 50 day moving average price of $68.44 and a two-hundred day moving average price of $69.40. The firm has a market cap of $733.97 million, a PE ratio of 6.49 and a beta of 0.58.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.